IndicationLiver diseases (injury, fibrosis, cirrhosis and cancer)
Fernández-Varo G et al. Hepatology. 2020
Human liver perfusion systems
- Investigation of the effects of novel drugs, adenovirus or nanoparticle therapies in a milieu that retains the architecture, interactions, and multicellular characteristics of the healthy and cirrhotic hepatic tissue using PCLS. Comparison between species.
- Hepatotoxicity studies.
- Cell distribution and ultrastructural analysis of treatment with nanoparticles.
- Evaluation of the dose-effect response of a new treatment in human hepatic cells.
Principal investigatorsWladimiro Jiménez, Pedro Melgar-Lesmes.
Well established pre-clinical tool to evaluate toxicity, therapeutic efficacy and dose-response of new drugs or functionalized nanoparticles in humans, and also in rats or mice.